In a matter involving an antitrust counterclaim, a generic pharmaceutical manufacturer alleged that a blockbuster brand manufacturer attempted to monopolize the market and delay entry of the generic product. A CRA expert was retained to analyze market definition, competitive effects, and lost profits damages estimates. The matter settled favorably for our client shortly before trial.
Charles River Associates announces six VP promotions
Charles River Associates today announced the promotions of six new vice presidents. Sean Sheridan in CRA’s Intellectual Property Practice, Eddie Li, Erika...